Viewing Study NCT03250832


Ignite Creation Date: 2025-12-24 @ 9:39 PM
Ignite Modification Date: 2026-02-19 @ 8:14 AM
Study NCT ID: NCT03250832
Status: COMPLETED
Last Update Posted: 2024-04-11
First Post: 2017-06-22
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors
Sponsor: Tesaro, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Advanced solid tumors View
None Dostarlimab View
None Ovarian cancer View
None Colorectal cancer View
None Lung cancer View
None Dose escalation View
None Dose expansion View